Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

The effects of dopaminergic D2 stimulation and blockade on smoking behavior.

Caskey NH, Jarvik ME, Wirshing WC.

Exp Clin Psychopharmacol. 1999 Feb;7(1):72-8.

PMID:
10036612
2.

Modulating tobacco smoking rates by dopaminergic stimulation and blockade.

Caskey NH, Jarvik ME, Wirshing WC, Madsen DC, Iwamoto-Schaap PN, Eisenberger NI, Huerta L, Terrace SM, Olmstead RE.

Nicotine Tob Res. 2002 Aug;4(3):259-66.

PMID:
12215234
3.

Dopamine D2 receptor effects on GABA(A) receptor expression may modify melanotrope peptide release.

Sands SA, de Blas AL, Chronwall BM.

Peptides. 1998;19(2):397-401.

PMID:
9493875
4.

Effects of dopaminergic modulation on electrophysiological brain response to affective stimuli.

Franken IH, Nijs I, Pepplinkhuizen L.

Psychopharmacology (Berl). 2008 Jan;195(4):537-46. Epub 2007 Sep 22.

5.

Dopamine D1- and D2-like receptor mechanisms in relapse to cocaine-seeking behavior: effects of selective antagonists and agonists.

Khroyan TV, Barrett-Larimore RL, Rowlett JK, Spealman RD.

J Pharmacol Exp Ther. 2000 Aug;294(2):680-7.

6.

The role of D2-like dopamine receptors in the locomotor stimulant effects of cocaine in mice.

Chausmer AL, Katz JL.

Psychopharmacology (Berl). 2001 Apr;155(1):69-77.

PMID:
11374338
7.

Dopamine D2 receptor stimulation inhibits angiotensin II-induced hypertrophy in cultured neonatal rat ventricular myocytes.

Li H, Shi S, Sun YH, Zhao YJ, Li QF, Li HZ, Wang R, Xu CQ.

Clin Exp Pharmacol Physiol. 2009 Mar;36(3):312-8. doi: 10.1111/j.1440-1681.2008.05064.x. Epub 2008 Oct 15.

PMID:
18986329
9.

Haloperidol reduces smoking of both nicotine-containing and denicotinized cigarettes.

Brauer LH, Cramblett MJ, Paxton DA, Rose JE.

Psychopharmacology (Berl). 2001 Dec;159(1):31-7. Epub 2001 Sep 4.

PMID:
11797066
10.

Effects of D2 dopamine receptor agonist and antagonist on brain activity in the rat assessed by functional magnetic resonance imaging.

Hagino H, Tabuchi E, Kurachi M, Saitoh O, Sun Y, Kondoh T, Ono T, Torii K.

Brain Res. 1998 Dec 7;813(2):367-73.

PMID:
9838195
11.

Effects of a partial D2-like receptor agonist on striatal dopamine autoreceptor functioning in preweanling rats.

Yoshida ST, Baella SA, Stuebner NM, Crawford CA, McDougall SA.

Brain Res. 2006 Feb 16;1073-1074:269-75. Epub 2006 Jan 19.

PMID:
16427034
12.

No effects of l-dopa and bromocriptine on psychophysiological parameters of human selective attention.

Oranje B, Gispen-de Wied CC, Westenberg HG, Kemner C, Verbaten MN, Kahn RS.

J Psychopharmacol. 2006 Nov;20(6):789-98. Epub 2006 Feb 14.

PMID:
16478755
13.

Effects of bromocriptine and haloperidol on prepulse inhibition of the acoustic startle response in man.

Abduljawad KA, Langley RW, Bradshaw CM, Szabadi E.

J Psychopharmacol. 1998;12(3):239-45.

PMID:
10958249
14.

Agentic extraversion modulates the cardiovascular effects of the dopamine D2 agonist bromocriptine.

Wacker J, Stemmler G.

Psychophysiology. 2006 Jul;43(4):372-81.

PMID:
16916433
15.

Hippocampal and cortical sensory gating in rats: effects of quinpirole microinjections in nucleus accumbens core and shell.

de Bruin NM, Ellenbroek BA, van Luijtelaar EL, Cools AR, Stevens KE.

Neuroscience. 2001;105(1):169-80.

PMID:
11483310
16.

Dopamine D2 receptor radiotracers [(11)C](+)-PHNO and [(3)H]raclopride are indistinguishably inhibited by D2 agonists and antagonists ex vivo.

McCormick PN, Kapur S, Seeman P, Wilson AA.

Nucl Med Biol. 2008 Jan;35(1):11-7. Epub 2007 Nov 19.

PMID:
18158938
17.

Bromocriptine protects dopaminergic neurons from levodopa-induced toxicity by stimulating D(2)receptors.

Takashima H, Tsujihata M, Kishikawa M, Freed WJ.

Exp Neurol. 1999 Sep;159(1):98-104.

PMID:
10486178
18.

Haloperidol reduces stimulant and reinforcing effects of ethanol in social drinkers.

Enggasser JL, de Wit H.

Alcohol Clin Exp Res. 2001 Oct;25(10):1448-56.

PMID:
11696664
19.

Dopaminergic involvement in the discriminative-stimulus effects of methamphetamine in rats.

Munzar P, Goldberg SR.

Psychopharmacology (Berl). 2000 Feb;148(2):209-16.

PMID:
10663437
20.

Effects of an acute D2-dopaminergic blockade on the somatosensory cortical responses in healthy humans: evidence from evoked magnetic fields.

Huttunen J, Kähkönen S, Kaakkola S, Ahveninen J, Pekkonen E.

Neuroreport. 2003 Aug 26;14(12):1609-12.

PMID:
14502085

Supplemental Content

Support Center